-
network “Heart–Brain Interfaces.” The creation of an Inserm Chair dedicated to the heart–brain interface will actively contribute to structuring this emerging field, in line with Inserm’s transversal
-
at the interface between fundamental immunology, translational research and therapeutic innovation, with the ambition to accelerate the development of next-generation immunotherapies. Particular attention will be
-
and innovation. Strategy of the host laboratory: The objective of the CRCT (U1037) is to attract and retain talented scientists who will become tomorrow’s leaders at the interface of molecular biology
-
, biomaterials, morphogenic factors and biophysical stimulation, explores 3D bioprinting and provides preclinical and clinical validation. It is located at the interface of cell therapy, smart biomaterials
-
agents and immune cells, as well as the mechanisms of the innate immune response and infection persistence, is a key challenge for analysing the pathogenesis of EIDs. This focus consolidates the interfaces